Lilly’s Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic...
Sanofi Expects $120 Million Hit As Dengue Vaccine Hits Major Snag
Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can...
Kyowa Hakko Kirin Submits the Partial Change Approval Application of Mogamulizumab in Japan
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai; announces the submission of a supplemental application to remove the requirement for...
Sankyo to Convert Kitasato Daiichi Sankyo Vaccine into Wholly Owned Subsidiary
Daiichi Sankyo Company, Limited announced that its Board of Directors approved a resolution to convert Daiichi Sankyo’s consolidated subsidiary, Kitasato Daiichi Sankyo Vaccine Co.,...
Allergan’s Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research
Allergan plc , a leading global pharmaceutical company, is pleased to announce that its manuscript, "Fluctuations in Episodic and Chronic Migraine Status Over the...
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a new clinical...
Daiichi Sankyo Launches Anticoagulant LixianaⓇ OD Tablets (orally disintegrating tablets) in Japan
Daiichi Sankyo Company, Limited announced that it has launched its oral anticoagulant LixianaⓇ OD Tablets 15 mg, 30 mg and 60 mg (generic name:...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...